KalVista focuses on the discovery, development and commercialization of small molecule protease inhibitors.
Business Model:
Revenue: $9.5M
Employees: 51-200
Address: 55 Cambridge Pkwy
City: Cambridge
State: MA
Zip: 02142
Country: US
KalVista focuses on the discovery, development and commercialization of small molecule protease inhibitors.
Contact Phone:
+18579990075
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/6/2015
Ticker Symbol:
KALV
IPO Price:
$17/share
Amount Raised:
$68M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2011 | Series A | 2 | $13.2M |
Novo Holdings SV Health Investors Novo Holdings SV Health Investors Novo Holdings SV Health Investors Novo Holdings SV Health Investors |
2/2021 | Post-IPO Equity | $193.5M | 12/2022 | Post-IPO Equity | $58M | 8/2011 | Series A | $13.2M |
Novo A/S SV Life Sciences |
11/2022 | Post-IPO Equity | $58M | 7/2015 | Series B | 5 | $33M |
Longwood Fund Venrock Novo Holdings SV Health Investors RA Capital Management RA Capital Management Longwood Fund Venrock Novo Holdings SV Health Investors RA Capital Management RA Capital Management |
---|
Announced Date | Name | Price |
---|---|---|
6/2016 | Carbylan Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|